BRUSSELS (Reuters) - The European Union could give final approval for the Pfizer-BioNTech COVID-19 vaccine as early as Dec. 23, a senior Commission official said on Wednesday, only two days after a possible green light from the bloc's regulator.
Under EU rules, the European Medicines Agency (EMA) recommends the approval of new medicines and vaccines, but the final decision to allow them onto the market is made by the EU executive Commission after consultation with EU governments.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!